7 research outputs found

    Fragmentation processes of ionized 5-fluorouracil in the gas phase and within clusters

    Get PDF
    We have measured mass spectra for positive ions produced from neutral 5-fluorouracil by electron impact at energies from 0 to 100 eV. Fragment ion appearance energies of this (radio-)chemotherapy agent have been determined for the first time and we have identified several new fragment ions of low abundance. The main fragmentations are similar to uracil, involving HNCO loss and subsequent HCN loss, CO loss, or FCCO loss. The features adjacent to these prominent peaks in the mass spectra are attributed to tautomerization preceding the fragmentation and/or the loss of one or two additional hydrogen atoms. A few fragmentions are distinct for 5-fluorouracil compared to uracil, most notably the production of the reactive moiety CF+. Finally, multiphoton ionization mass spectra are compared for 5-fluorouracil from a laser thermal desorption source and from a supersonic expansion source. The detection of a new fragment ion at 114 u in the supersonic expansion experiments provides the first evidence for a clustering effect on the radiation response of 5-fluorouracil. By analogy with previous experiments and calculations on protonated uracil, this is assigned to NH3 loss from protonated 5-fluorouracil

    Morphological and immunohistochemical peculiarities of oncomarkers in placental barrier

    No full text
    Histological and electron microscopy investigations in 47% cases showed disorders of microcirculation with haemorrage and excessive deposits of extravillous fi brinoid with presence of pycnosis and nucleus polymorphism. In 1st investigation group in I pregnancy trimester in placental barrier structures there were pronounced expression of proliferative marker (Ki-67), protein p53 and decrease of these markers in III trimester that is proved by indexes of proliferation and it is caused by regulating infl uence of these factors on the processes of growth, development, differentiation and cell death in placental barrier structures in pregnancy course. In 2nd group pronounced Ki-67 expression in noted in cytotrophoblast nuclei and less pronounced - in stromal cells and endothelium of vesels that is confi rmed by signifi cant increase of proliferative index. Expression of protein 53 was focal in nuclei of extravilleus trophoblast as compared with negative one in control group. It was noted that oncofetal antigen in 1st group showed trace reaction in cytotrophoblast in early terms of gestation (I trimester) and it was not determined in III trimester of pregnancy. In 2nd group in III trimester pronounced immunoreactivity of oncofetal antigen in cytoplasm of stroma cellular elements (Hofbauer cells, fi broblasts) was noted. Pronounced expression of fundamental marker of cell differentiation of cytokeratin in cyto- and syncytiotrophoblast in pregnancy course shows that differentiation processes in placental barrier take place before term labor

    Combined vaccines in the national prevention immunization schedules for the children in Belarus, Kazakhstan, Russia and Ukraine

    No full text
    Π•he announcement of the east European expert group for vaccine prevention presents position of the leading specialists of Russia, Belarus, Ukraine and Kazakhstan on key issues of the national pre vention immunization schedule. the authors examine in detail the aspects of vaccination against hepatitis type b, including optimal term of injection of the first vaccine dose, vaccination tactics for the premature and low weight newborns, safety of recombinant vaccines against hepatitis type Π². based on the analysis of the morbidity of h. influenzae type b invasive forms along with the methods recommended by who (HIB RAT), experts recommend introduction of the vaccine against this infection into the prevention immunization schedule. The experts believe the basis for the combined vaccines in pediatrics to be the vaccines with cellfree pertussis component. This class of vaccines allows introducing the additional booster dose of pertussis vaccines for immunization of the preschool children into the immunization schedule, which is dictated by the present epidemic situation with due account for this infection. The experts note the importance of application of the combined vaccines in pediatrics, whose wide implementation into healthcare system practices is in the interests of the parents, medical officers and society.Key words: hepatitis type Π², h. influenzae type b, HIB RAT, pertussis, diphteria and tetanus toxoids and pertussis vaccine, poliovaccines, combined vaccines, prevention immunization schedule, children

    Combined vaccines in the national prevention immunization schedules for the children in Belarus, Kazakhstan, Russia and Ukraine

    No full text
    Π•he announcement of the east European expert group for vaccine prevention presents position of the leading specialists of Russia, Belarus, Ukraine and Kazakhstan on key issues of the national pre vention immunization schedule. the authors examine in detail the aspects of vaccination against hepatitis type b, including optimal term of injection of the first vaccine dose, vaccination tactics for the premature and low weight newborns, safety of recombinant vaccines against hepatitis type Π². based on the analysis of the morbidity of h. influenzae type b invasive forms along with the methods recommended by who (HIB RAT), experts recommend introduction of the vaccine against this infection into the prevention immunization schedule. The experts believe the basis for the combined vaccines in pediatrics to be the vaccines with cellfree pertussis component. This class of vaccines allows introducing the additional booster dose of pertussis vaccines for immunization of the preschool children into the immunization schedule, which is dictated by the present epidemic situation with due account for this infection. The experts note the importance of application of the combined vaccines in pediatrics, whose wide implementation into healthcare system practices is in the interests of the parents, medical officers and society.Key words: hepatitis type Π², h. influenzae type b, HIB RAT, pertussis, diphteria and tetanus toxoids and pertussis vaccine, poliovaccines, combined vaccines, prevention immunization schedule, children

    ΠšΠžΠœΠ‘Π˜ΠΠ˜Π ΠžΠ’ΠΠΠΠ«Π• Π’ΠΠšΠ¦Π˜ΠΠ« Π’ ΠΠΠ¦Π˜ΠžΠΠΠ›Π¬ΠΠ«Π₯ ΠšΠΠ›Π•ΠΠ”ΠΠ Π―Π₯ ΠŸΠ ΠžΠ€Π˜Π›ΠΠšΠ’Π˜Π§Π•Π‘ΠšΠ˜Π₯ ΠŸΠ Π˜Π’Π˜Π’ΠžΠš Π”Π›Π― Π”Π•Π’Π•Π™ Π’ Π‘Π•Π›ΠΠ Π£Π‘Π˜, ΠšΠΠ—ΠΠ₯БВАНЕ, РОББИИ И Π£ΠšΠ ΠΠ˜ΠΠ•. Π—ΠΠ―Π’Π›Π•ΠΠ˜Π• Π“Π Π£ΠŸΠŸΠ« Π­ΠšΠ‘ΠŸΠ•Π Π’ΠžΠ’ Π’ ΠžΠ‘Π›ΠΠ‘Π’Π˜ Π’ΠΠšΠ¦Π˜ΠΠžΠŸΠ ΠžΠ€Π˜Π›ΠΠšΠ’Π˜ΠšΠ˜

    No full text
    Π•he announcement of the east European expert group for vaccine prevention presents position of the leading specialists of Russia, Belarus, Ukraine and Kazakhstan on key issues of the national pre vention immunization schedule. the authors examine in detail the aspects of vaccination against hepatitis type b, including optimal term of injection of the first vaccine dose, vaccination tactics for the premature and low weight newborns, safety of recombinant vaccines against hepatitis type Π². based on the analysis of the morbidity of h. influenzae type b invasive forms along with the methods recommended by who (HIB RAT), experts recommend introduction of the vaccine against this infection into the prevention immunization schedule. The experts believe the basis for the combined vaccines in pediatrics to be the vaccines with cellfree pertussis component. This class of vaccines allows introducing the additional booster dose of pertussis vaccines for immunization of the preschool children into the immunization schedule, which is dictated by the present epidemic situation with due account for this infection. The experts note the importance of application of the combined vaccines in pediatrics, whose wide implementation into healthcare system practices is in the interests of the parents, medical officers and society.Key words: hepatitis type Π², h. influenzae type b, HIB RAT, pertussis, diphteria and tetanus toxoids and pertussis vaccine, poliovaccines, combined vaccines, prevention immunization schedule, children.ЗаявлСниС Восточно-ЕвропСйской экспСртной Π³Ρ€ΡƒΠΏΠΏΡ‹ ΠΏΠΎ Π²Π°ΠΊΡ†ΠΈΠ½ΠΎΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΠ΅ прСдставляСт ΠΏΠΎΠ·ΠΈΡ†ΠΈΡŽ Π²Π΅Π΄ΡƒΡ‰ΠΈΡ… спСциалистов России, БСларуси, Π£ΠΊΡ€Π°ΠΈΠ½Ρ‹ ΠΈ ΠšΠ°Π·Π°Ρ…ΡΡ‚Π°Π½Π° ΠΏΠΎ ΠΊΠ»ΡŽΡ‡Π΅Π²Ρ‹ΠΌ вопросам развития Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΊΠ°Π»Π΅Π½Π΄Π°Ρ€Π΅ΠΉ профилактичСских ΠΏΡ€ΠΈΠ²ΠΈΠ²ΠΎΠΊ. ΠŸΠΎΠ΄Ρ€ΠΎΠ±Π½ΠΎ рассмотрСны аспСкты Π²Π°ΠΊΡ†ΠΈΠ½Π°Ρ†ΠΈΠΈ ΠΏΡ€ΠΎΡ‚ΠΈΠ² Π³Π΅ΠΏΠ°Ρ‚ΠΈΡ‚Π° Π’, Π² Ρ‚ΠΎΠΌ числС – ΠΎΠΏΡ‚ΠΈΠΌΠ°Π»ΡŒΠ½Ρ‹ΠΉ срок ввСдСния ΠΏΠ΅Ρ€Π²ΠΎΠΉ Π΄ΠΎΠ·Ρ‹ Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹, Ρ‚Π°ΠΊΡ‚ΠΈΠΊΠ° Π²Π°ΠΊΡ†ΠΈΠ½Π°Ρ†ΠΈΠΈ Π½Π΅Π΄ΠΎΠ½ΠΎΡˆΠ΅Π½Π½Ρ‹Ρ… ΠΈ маловСсных Π΄Π΅Ρ‚Π΅ΠΉ, Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡ‚ΡŒ Ρ€Π΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½Ρ‚Π½Ρ‹Ρ… Π²Π°ΠΊΡ†ΠΈΠ½ ΠΏΡ€ΠΎΡ‚ΠΈΠ² Π³Π΅ΠΏΠ°Ρ‚ΠΈΡ‚Π° Π’. На основании Π°Π½Π°Π»ΠΈΠ·Π° заболСваСмости ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½Ρ‹ΠΌΠΈ Ρ„ΠΎΡ€ΠΌΠ°ΠΌΠΈ H. influenzae Ρ‚ΠΈΠΏΠ° b с использованиСм ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠ², Ρ€Π΅ΠΊΠΎΠΌΠ΅Π½Π΄ΠΎΠ²Π°Π½Π½Ρ‹Ρ… Π’ΠžΠ— (Hib-RAT), экспСрты Ρ€Π΅ΠΊΠΎΠΌΠ΅Π½Π΄ΡƒΡŽΡ‚ Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅ Π²Π°ΠΊΡ†ΠΈΠ½Π°Ρ†ΠΈΠΈ ΠΏΡ€ΠΎΡ‚ΠΈΠ² этой ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ Π² ΠΊΠ°Π»Π΅Π½Π΄Π°Ρ€ΠΈ профилактичСских ΠΏΡ€ΠΈΠ²ΠΈΠ²ΠΎΠΊ. Основой ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡ€ΠΎΠ²Π°Π½Π½Ρ‹Ρ… Π²Π°ΠΊΡ†ΠΈΠ½ Π² ΠΏΠ΅Π΄ΠΈΠ°Ρ‚Ρ€ΠΈΠΈ экспСрты ΡΡ‡ΠΈΡ‚Π°ΡŽΡ‚ Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹ с бСсклСточным ΠΊΠΎΠΊΠ»ΡŽΡˆΠ½Ρ‹ΠΌ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚ΠΎΠΌ. Π”Π°Π½Π½Ρ‹ΠΉ класс Π²Π°ΠΊΡ†ΠΈΠ½ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ‚ ввСсти Π² ΠΊΠ°Π»Π΅Π½Π΄Π°Ρ€ΡŒ ΠΏΡ€ΠΈΠ²ΠΈΠ²ΠΎΠΊ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡ‚Π΅Π»ΡŒΠ½ΡƒΡŽ Ρ€Π΅Π²Π°ΠΊΡ†ΠΈΠ½ΠΈΡ€ΡƒΡŽΡ‰ΡƒΡŽ Π΄ΠΎΠ·Ρƒ коклюшной Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹ для ΠΈΠΌΠΌΡƒΠ½ΠΈΠ·Π°Ρ†ΠΈΠΈ дошкольников, Ρ‡Ρ‚ΠΎ диктуСтся настоящСй эпидСмичСской ситуациСй ΠΏΠΎ Π΄Π°Π½Π½ΠΎΠΉ ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ. ЭкспСрты ΠΎΡ‚ΠΌΠ΅Ρ‡Π°ΡŽΡ‚ Ρ†Π΅Π½Π½ΠΎΡΡ‚ΡŒ примСнСния ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡ€ΠΎΠ²Π°Π½Π½Ρ‹Ρ… Π²Π°ΠΊΡ†ΠΈΠ½ Π² ΠΏΠ΅Π΄ΠΈΠ°Ρ‚Ρ€ΠΈΠΈ, ΡˆΠΈΡ€ΠΎΠΊΠΎΠ΅ Π²Π½Π΅Π΄Ρ€Π΅Π½ΠΈΠ΅ ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… Π² ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΡƒ здравоохранСния ΠΎΡ‚Π²Π΅Ρ‡Π°Π΅Ρ‚ интСрСсам Ρ€ΠΎΠ΄ΠΈΡ‚Π΅Π»Π΅ΠΉ, мСдицинских Ρ€Π°Π±ΠΎΡ‚Π½ΠΈΠΊΠΎΠ² ΠΈ общСства Π² Ρ†Π΅Π»ΠΎΠΌ. ΠšΠ»ΡŽΡ‡Π΅Π²Ρ‹Π΅ слова: Π³Π΅ΠΏΠ°Ρ‚ΠΈΡ‚ Π’, H. influenzae Ρ‚ΠΈΠΏΠ° B, Hib-RAT, коклюш, ΠΠšΠ”Π‘, ΠΏΠΎΠ»ΠΈΠΎΠ²Π°ΠΊΡ†ΠΈΠ½Ρ‹, ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡ€ΠΎΠ²Π°Π½Π½Ρ‹Π΅ Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹, ΠΊΠ°Π»Π΅Π½Π΄Π°Ρ€ΡŒ профилактичСских ΠΏΡ€ΠΈΠ²ΠΈΠ²ΠΎΠΊ, Π΄Π΅Ρ‚ΠΈ.(ΠŸΠ΅Π΄ΠΈΠ°Ρ‚Ρ€ΠΈΡ‡Π΅ΡΠΊΠ°Ρ фармакология. – 2007; 4(1):6-18
    corecore